The importance of non-transferrin bound iron in disorders of iron metabolism

Transfusion Science

Volumn 23, Issue 3, 2000, Pages 185-192

  Breuer, W ^a   Hershko, C ^b   Cabantchik, Z I ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; TRANSFERRIN;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON BINDING CAPACITY; IRON CHELATION; IRON METABOLISM; IRON OVERLOAD; IRON THERAPY; NEWBORN; PATHOPHYSIOLOGY;

HUMANS; IRON; IRON METABOLISM DISORDERS; TRANSFERRIN;

EID: 0033677772     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(00)00087-4     Document Type: Article

References (49)

1. Nonspecific serum iron in thalassaemia: An abnormal serum iron fraction of potential toxicity
2. Nonspecific serum iron in thalassemia: Quantitation and chemical reactivity
3. Stoichiometric and site characteristics of the binding of iron to human transferrin
4. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation
5. Discovery of the ceruloplasmin homologue hephaestin: New insight into the copper/iron connection
6. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux
7. Non-transferrin bound iron in plasma or serum from patients with idiopathic hemochromatosis
8. Interaction of serum albumin with the Fe (III)-citrate complex
9. Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin bound iron (NTBI) used for assessing chelation therapy
10. A non-transferrin-bound serum iron in idiopathic hemochromatosis
11. Nontransferrin-bound iron in plasma from hemochromatosis patients: Effect of phlebotomy therapy
12. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin
13. The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation
14. Characterization of non-transferrin-bound iron clearance by rat liver
15. The surface of rat hepatocytes can transfer iron from stable chelates to external acceptors
16. Ultrastructural sequences during liver iron overload in genetic hemochromatosis
17. Time-course of iron overload and biochemical, histopathological and ultrastructural evidence of pancreatic damage in hypotransferrinaemic mice
18. Iron release from human monocytes after erythrophagocytosis in vitro: An investigation in normal subjects and hereditary hemochromatosis patients
19. The purification and properties of ferritin from human serum
20. Serum ferritin iron, a new test, measures human body iron stores unconfounded by inflammation
21. Quantitation of ferritin iron in plasma, an explanation for non-transferrin iron
22. Iron mobilization from ferritin by chelating agents
23. Reductive mobilisation of ferritin iron
24. New concepts of iron and aluminium chelation therapy with oral L1 (deferiprone) and other chelators
25. A direct method for quantification of non-transferrin bound iron
26. Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy
27. Bleomycin detectable iron in serum from laeukemiac patients before and after chemotherapy
28. Non-transferrin bound iron and neutropenia after cytotoxic chemotherapy
29. Non-transferrin-bound iron induced by myeloablative chemotherapy
30. Transient iron-overload with bleomycin-detectable iron present during cardiopulmonary bypass surgery
31. Antioxidant protection against iron toxicity: Plasma changes during cardiopulmonary bypass in neonates, infants, and children
32. Iron overload in paediatrics undergoing cardiopulmonary bypass
33. Bleomycin-detectable iron in the plasma of premature and full-term neonates
34. Chromatographic method for the determination of non-transferrin-bound iron suitable for use on the plasma and bronchoalveolar lavage fluid of preterm babies
35. Measurement of iron and copper in biological systems: Bleomycin and copper-phenanthroline assays
36. Analysis of serum non-transferrin-bound iron by a high-throughput fluorescence assay
37. Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method
38. Role of free radicals and catalytic metal ions in human disease: An overview
39. Free radicals and antioxidants in the year 2000. A historical look to the future
40. Pathophysiology of iron-overload
41. Blood antioxidant status and urinary levels of catecholamine metabolites in beta-thalassemia
42. The iron hypothesis - Does iron cause atherosclerosis
43. Association between body iron stores and the risk of acute myocardial infarction in men
44. Iron, atherosclerosis, and ischemic heart disease
45. Oxidants and antioxidants in the pathogenesis of atherosclerosis. Implications for the oxidized low density lipoprotein hypothesis
46. Regulation of the transferrin-independent iron transport system in cultured cells
47. Regulating the fate of mRNA: The control of cellular iron metabolism
48. Limitations of ferritin as a marker of anemia in end stage renal disease
49. Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1